← Open Payments lookup

PATRICK HANDLIN: Open Payments

NPI 1366421711 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,334 in 82 payments from 11 companies in 2025. Trend: 2023 $2,266 · 2024 $1,673 · 2025 $1,334

Food & beverage: $1,334
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.23$401
ABBVIE INC.28$377
Otsuka America Pharmaceutical, Inc.17$267
Janssen Pharmaceuticals, Inc3$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$57
Alkermes, Inc.2$50
Takeda Pharmaceuticals U.S.A., Inc.2$34
Axsome Therapeutics, Inc.1$24
Lundbeck LLC1$16
Vanda Pharmaceuticals Inc.1$15

Products named: INGREZZA, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, ARISTADA, TRINTELLIX.

Industry payments across MI — which companies pay providers there.